⌕
Charles River Laboratories International · CRL · NYSE
Tenet 33 · Weak
Compare
$332.57−0.88%Market openTenet 33 · Weak
$332.57−2.95 (−0.88%)
Market open · 15-min delayed · as of 3:03 PM ET· NYSE · USD

Charles River Laboratories International (CRL) Stock

Charles River Laboratories International (CRL) has a Tenet Score of 33 of 100 against 340 Healthcare peers, as of Nov 16, 2026.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

Key stats

Market cap
$16.1B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
405.6×
TTM through Sep 26, 2026 · as of close, Nov 16, 2026
52-week range
146.19 – 379.63
low → high · as of close, Nov 16, 2026
Tenet Score
33/100
Weak · 340 Healthcare peers

Industry: Health Services

Charles River Laboratories International Inc. scores 33/100. Weak. Financial health is the soft spot, trading at 406× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
33/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
18
Quality
53
Health
17
Growth
43

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityCHealthFGrowthDMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
5.0×
Sep 26, 2026 balance sheet
P/S
4.0×
price to sales, TTM through Sep 26, 2026 · as of close, Nov 16, 2026
ROE
1%
TTM through Sep 26, 2026
Operating margin
0.6%
fiscal 2025, before interest and tax
Net margin
1.0%
TTM through Sep 26, 2026
Current ratio
1.41
Sep 26, 2026 balance sheet
Net debt / EBITDA
5.1×
TTM through Sep 26, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Charles River Laboratories International Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It ope…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 202 US ETFs · top wrappers by weightSee all ETFs holding CRL →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Charles River Laboratories International in?

Charles River Laboratories International is in the Healthcare sector and the Health Services industry.

What is Charles River Laboratories International's Tenet Score?

Charles River Laboratories International's Tenet Score is 33 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.